FOXO Technologies Announces Strategic Transaction and Board Expansion
Company Announcements

FOXO Technologies Announces Strategic Transaction and Board Expansion

FOXO Technologies ( (FOXO) ) has shared an announcement.

Rennova Health, Inc. and its subsidiary engaged in a strategic transaction involving a stock exchange agreement with another company, amending the original terms to include a cash consideration and a $22 million senior note, secured by assets and guaranteed by the involved companies. The note, with a two-year maturity and a tiered interest rate, mandates repayments based on free cash flow and can be offset by future equity capital proceeds. Additionally, the company’s board of directors has been expanded with two new appointments, bringing valuable experience in healthcare and financial consulting to the team.

For detailed information about FOXO stock, go to TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskFOXO Technologies Issues New Stock and Negotiates Debt
TipRanks Auto-Generated NewsdeskFOXO Technologies Advances in AI-Driven Healthcare Growth
TheFlyFoxo Technologies provides shareholder letter from Interim CEO
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App